Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 9903, October 15, 2006. doi: 10.1158/0008-5472.CAN-06-0002
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, A. P. P.
Right arrow Articles by Khan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, A. P. P.
Right arrow Articles by Khan, M.

Cell, Tumor, and Stem Cell Biology

Cleavage of Misfolded Nuclear Receptor Corepressor Confers Resistance to Unfolded Protein Response–Induced Apoptosis

Angela Ping Ping Ng1,4, Jek Howe Fong1, Dawn Sijin Nin1, Jayshree L. Hirpara2, Norio Asou5, Chien-Shing Chen1,3, Shazib Pervaiz1,2,4 and Matiullah Khan1,3

1 Oncology Research Institute, Departments of 2 Physiology and 3 Medicine, Yong Loo Lin School of Medicine and 4 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore; and 5 Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

Requests for reprints: Matiullah Khan, Oncology Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Clinical Research Center, Block MD11, 10 Medical Drive, Singapore 117597. Phone: 65-6874-8055; Fax: 65-6873-9664; E-mail: nmimmk{at}nus.edu.sg or Shazib Pervaiz. Phone: 65-6874-6602; Fax: 65-6778-8161; E-mail: phssp{at}nus.edu.sg.

We have recently reported that accumulation of misfolded nuclear hormone receptor corepressor (N-CoR) as insoluble protein aggregates in acute promyelocytic leukemia (APL) cells induces endoplasmic reticulum (ER) stress and activates unfolded protein response (UPR). Although accumulation of misfolded proteins is known to trigger UPR-induced cytotoxic cell death in several neurodegenerative disorders, APL cells are notably resistant to UPR-induced apoptosis. The molecular basis for the paradoxical response of APL cells to UPR is not known. Here, we report that a glycoprotease, selectively expressed in APL cells, regulates the response of APL cells to UPR-induced apoptosis through processing of misfolded N-CoR protein. Results show that misfolded N-CoR is cleaved selectively in APL cells, and cellular extracts of APL cells and human primary APL cells contain activity that cleaves N-CoR protein. Purification and spectrometric analysis of N-CoR cleaving activity from an APL cell line reveals that it is a glycoprotein endopeptidase known as OSGEP. Furthermore, the cleavage of N-CoR in APL cells could be blocked by the broad-spectrum protease inhibitor AEBSF and by RNA interference–mediated down-regulation of OSGEP expression. AEBSF selectively inhibits growth and promotes apoptosis of APL cells possibly through a mechanism involving AEBSF-induced accumulation of insoluble N-CoR protein and by triggering ER stress. Taken together, these findings suggest that selective induction of protease activity in APL cells may represent a novel cytoprotective component of UPR, which could be exploited by tumor cells to survive the toxic insult of misfolded protein(s). (Cancer Res 2006; 66(20): 9903-12)




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. I. Handford, B. Ize, G. Buchanan, G. P. Butland, J. Greenblatt, A. Emili, and T. Palmer
Conserved Network of Proteins Essential for Bacterial Viability
J. Bacteriol., August 1, 2009; 191(15): 4732 - 4749.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. Schardt, D. Weber, M. Eyholzer, B. U. Mueller, and T. Pabst
Activation of the Unfolded Protein Response Is Associated with Favorable Prognosis in Acute Myeloid Leukemia
Clin. Cancer Res., June 1, 2009; 15(11): 3834 - 3841.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Hecker, N. Leulliot, D. Gadelle, M. Graille, A. Justome, P. Dorlet, C. Brochier, S. Quevillon-Cheruel, E. Le Cam, H. van Tilbeurgh, et al.
An archaeal orthologue of the universal protein Kae1 is an iron metalloprotein which exhibits atypical DNA-binding properties and apurinic-endonuclease activity in vitro
Nucleic Acids Res., September 25, 2007; 35(18): 6042 - 6051.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. P. P. Ng, D. S. Nin, J. H. Fong, D. Venkataraman, C.-S. Chen, and M. Khan
Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein
Mol. Cancer Ther., August 1, 2007; 6(8): 2240 - 2248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Reineke, H. Liu, M. Lam, Y. Liu, and H.-Y. Kao
Aberrant Association of Promyelocytic Leukemia Protein-Retinoic Acid Receptor-{alpha} with Coactivators Contributes to Its Ability to Regulate Gene Expression
J. Biol. Chem., June 22, 2007; 282(25): 18584 - 18596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.